Annis Gardner Whiting Capital Advisors, LLC Novo Nordisk A S Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $355 Billion
- Q3 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 1,481 shares of NVO stock, worth $158,170. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,481
Previous 2,307
35.8%
Holding current value
$158,170
Previous $329 Million
46.45%
% of portfolio
0.05%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding NVO
# of Institutions
1,955Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$2.16 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.53 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.53 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.42 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.3 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $241B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...